A Billionaire Insider Bought This Healthcare Stock

On October 25th, St. Jude Medical, Inc. (NYSE:STJ) Board member John Brown purchased 25,000 shares of the company’s stock at an average price of $38.65 per share- an investment of nearly $1 million. Brown, a billionaire and former CEO of Stryker, joined the St. Jude Board in 2005. Insider purchases should be good signs for a stock: since an insider already has a strong economic connection to the company, it is rational for them to diversify their wealth away from the same company unless they are particularly confident that the stock price is going to rise in the future. We believe that this is why, statistically, stocks that are bought by insiders tend to outperform the market (learn more about studies of insider trading). St. Jude Medical, Inc. provides medical appliances and equipment, mostly products which are used in diagnosing and treating cardiac and cardiovascular conditions.

Revenue was down slightly in the third quarter of 2012 compared to the third quarter of last year according to the company’s report, after having been flat in the first half of the year from the same period in 2011. The company did some cost cutting, but a special charge resulted in earnings being down 22% (adjusted earnings were up 2%). The charges were due to restructuring events in one of St. Jude’s business segments. The stock is down 2% in the last year, while broader market indices have risen. Wall Street analysts are optimistic, anticipating moderate earnings growth over the next year which prices the company at only 11 times forward estimates. Adjusted net earnings per share are on track for $3.41 per share; this would imply a current-year P/E of 11 as well. We think that this looks like a good price if the business can continue to deliver steady results once it is no longer taking special charges.

AQR CAPITAL MANAGEMENT

Phil Gross and Robert Atchinson’s Adage Capital Management cut its stake in St. Jude Medical, Inc. over the course of the second quarter but still owned 2.3 million shares at the end of June (find more stocks that Adage owned). AQR Capital Management, which is managed by Cliff Asness, had a relatively small position at the beginning of April but bought the stock over the next three months to finish the quarter with a total of about 690,000 shares (see more stock picks from Cliff Asness).

Other healthcare equipment companies include Boston Scientific Corporation (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), Medtronic, Inc. (NYSE:MDT), and Varian Medical Systems, Inc. (NYSE:VAR). Medtronic and Boston Scientific are priced similarly to St. Jude at forward P/E multiples of 11. Medtronic, easily the largest of these companies by market cap (it is over three times as valuable as St. Jude), actually trades at only 12 times trailing earnings, so it has very little to do in order to meet analyst targets and, at a 2.5% dividend yield, looks like a value stock as well. Boston Scientific reported a large net loss during the third quarter, which stemmed partly from lower earnings in key business segments; with these other companies looking more stable at similar multiples, we’d avoid that stock.

Edwards is priced much more for growth; its $10 billion market cap represents a multiple of 27 times analyst consensus for its 2013 earnings. Earnings in the third quarter were strong- up 34% from the same period in 2011- but was based on a considerably smaller revenue growth rate, so we’re not sure if net income can continue to grow at a similar pace for a long enough time to justify the stock price. Varian has also been delivering good growth recently, with its earnings also up at a double-digit rate in its most recent quarter versus a year earlier. Its earnings multiples tend to be in the teens, as expectations for continued growth give it a premium relative to peers like St. Jude and Medtronic. We might look at it in more detail, but for now would prefer the low growth and low pricing- and therefore, in our minds, lower risk- of those two companies.

We think that Brown has made a good purchase here. St. Jude looks cheap and its business appears to be doing fine, and unless investors study the company and Medtronic in more detail and find the latter even more attractive we think that it is a value play.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!